In vivo reflectance confocal microscopy as a response monitoring tool for actinic keratoses undergoing cryotherapy and photodynamic therapy
Name:
cancers-13-05488-v2.pdf
Size:
738.7Kb
Format:
PDF
Description:
Final Published Version
Author
Curiel-Lewandrowski, C.Myrdal, C.N.
Saboda, K.
Hu, C.
Arzberger, E.
Pellacani, G.
Legat, F.J.
Ulrich, M.
Hochfellner, P.
Oliviero, M.C.
Pasquali, P.
Gill, M.
Hofmann-Wellenhof, R.
Affiliation
Division of Dermatology, The University of Arizona College of MedicineThe University of Arizona Cancer Center
Department of Epidemiology and Biostatistics, Mel and Zuckerman College of Public Health, The University of Arizona
Issue Date
2021Keywords
Actinic keratosisCryotherapy
Photodynamic therapy
RCM
Reflectance confocal microscopy
Response monitoring
Metadata
Show full item recordPublisher
MDPICitation
Curiel-Lewandrowski, C., Myrdal, C. N., Saboda, K., Hu, C., Arzberger, E., Pellacani, G., Legat, F. J., Ulrich, M., Hochfellner, P., Oliviero, M. C., Pasquali, P., Gill, M., & Hofmann-Wellenhof, R. (2021). In vivo reflectance confocal microscopy as a response monitoring tool for actinic keratoses undergoing cryotherapy and photodynamic therapy. Cancers.Journal
CancersRights
Copyright © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Reflectance confocal microscopy (RCM) presents a non-invasive method to image actinic keratosis (AK) at a cellular level. However, RCM criteria for AK response monitoring vary across studies and a universal, standardized approach is lacking. We aimed to identify reliable AK response criteria and to compare the clinical and RCM evaluation of responses across AK severity grades. Twenty patients were included and randomized to receive either cryotherapy (n = 10) or PDT (n = 10). Clinical assessment and RCM evaluation of 12 criteria were performed in AK lesions and photodamaged skin at baseline, 3 and 6 months. We identified the RCM criteria that reliably characterize AK at baseline and display significant reduction following treatment. Those with the highest baseline odds ratio (OR), good interobserver agreement, and most significant change over time were atypical honeycomb pattern (OR: 12.7, CI: 5.7–28.1), hyperkeratosis (OR: 13.6, CI: 5.3–34.9), stratum corneum disruption (OR: 7.8, CI: 3.5–17.3), and disarranged epidermal pattern (OR: 6.5, CI: 2.9–14.8). Clinical evaluation demonstrated a significant treatment response without relapse. However, in grade 2 AK, 10/12 RCM parameters increased from 3 to 6 months, which suggested early subclinical recurrence detection by RCM. Incorporating standardized RCM protocols for the assessment of AK may enable a more meaningful comparison across clinical trials, while allowing for the early detection of relapses and evaluation of biological responses to therapy over time. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.Note
Open access journalISSN
2072-6694Version
Final published versionae974a485f413a2113503eed53cd6c53
10.3390/cancers13215488
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Copyright © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).